论文部分内容阅读
恶性淋巴瘤化、放疗通常有效,但某些病例却对常用化疗抗拒或退缩后很快复发,被称为“难治性淋巴瘤”。近年我们采用诺维本联合顺铂、VP16治疗27例难治性非何杰金淋巴瘤,取得较好疗效。报告如下。1 材料与方法:1.1 临床资料:本组27例,均经病理学诊断为非何杰金氏淋巴瘤(NHL),且全部为难治性病例。K 氏评分60～90分;男性19例,女性8例,年龄17～79岁,平均45.5岁。低度恶性2例,中度恶性14例,高度恶性11例。ⅡA期1例,
Malignant lymphoma metastasis and radiotherapy are usually effective, but some cases relapse soon after resisting or shrinking commonly used chemotherapy, which is called “refractory lymphoma.” In recent years, we have used Novybenz combined with cisplatin and VP16 to treat 27 cases of refractory non-Hodgkin’s lymphoma and achieved better results. The report is as follows. 1 Materials and methods: 1.1 Clinical data: 27 patients in this group were all pathologically diagnosed as non-Hodgkin’s lymphoma (NHL) and all were refractory cases. K score 60 to 90 points; 19 males and 8 females, aged 17 to 79 years, mean 45.5 years. There were 2 cases of low grade malignancy, 14 cases of moderate malignancy and 11 cases of high grade malignancy. Stage IIA, 1 case,